LXEO·52886X107·US·equity·Healthcare - Biotechnology-13D/G
LXEO (LEXEO THERAPEUTICS INC) is held by 81 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($29.3M), RA CAPITAL MANAGEMENT, L.P. ($28.7M), JANUS HENDERSON GROUP PLC ($28.5M). Net institutional sentiment: Mixed.
See how LXEO's score breaks down across 4 SEC sources
Showing 1-20 of 90
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer